Contact Us Today!

617-523-7900

or Use Our Simple Online Form to Give Us Feedback

We welcome your comments and feedback. Please include contact information if you'd like a response.

Did you find this page helpful?





If you would like a response, please include your contact information.

<< Return to Search Results

Eliot L. Berson,  M.D.

Photo of Eliot L. Berson,  M.D.
Director, Electroretinography Service
Specialties: Electroretinography
Retinal Degenerations
Phone Number: 617-573-3621
Fax: 617-573-3661
Location: 243 Charles Street
ERG Service
Boston, MA 02114
Office Hours: Weekdays (appointments involve a full day of testing)
Board Certification: Ophthalmology
Medical School Harvard Medical School
Residency Barnes and MacMillan Hospital (Ophthalmology)
Fellowship National Institutes of Health
Teaching Affiliation William F. Chatlos Professor of Ophthalmology, Harvard Medical School
Biographical Profile:


Dr. Eliot L. Berson, a board certified ophthalmologist, is the William F. Chatlos Professor of Ophthalmology and Director of Harvard Medical School’s Berman-Gund Laboratory for the Study of Retinal Degenerations at Massachusetts Eye and Ear. The Laboratory performs multidisciplined research to discover the causes, understand the pathogenesis, and seek means for treatment of retinitis pigmentosa, Usher syndrome, macular degeneration, and allied retinal degenerative diseases. He also is Director of the Electroretinography (ERG) Service at Mass. Eye and Ear where he evaluates patients with retinitis pigmentosa and allied retinal diseases who come for diagnosis, prognosis, and treatment where appropriate.

Clinical Interests

Hereditary retinal degenerations including retinitis pigmentosa

Research Interests

Hereditary retinal degenerations

What would you like your patients to know about you?

Evaluates in consultation patients age 6 and over with hereditary retinal disease or suspected retinal disease on referral from the patient’s physician. Evaluation requires an entire day in the ERG (Electroretinography) Service.

Publications

For a full publication list, please see his CV. A representative list (2006 - 2013) is available through www.pubmed.gov. 

Nishiguchi KM, Tearle RG, Liu YP, Oh EC, Miyake N, Benaglio P, Harper S, Koskiniemi-Kuendig H, Venturini G, Sharon D, Koenekoop RK, Nakamura M, Kondo M, Ueno S, Yasuma TR, Beckmann JS, Ikegawa S, Matsumoto N, Terasaki H, Berson EL, Katsanis N, Rivolta C. Whole genome sequencing in patients with retinitis pigmentosa reveals pathogenic DNA structural changes and NEK2 as a new disease gene. Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16139-44. 

Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Willett WC. ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol. 2012 Jun;130(6):707-11. 

Berson EL. Long-term visual prognoses in patients with retinitis pigmentosa. Exp Eye Res. 2007 Jul;85(1):7-14.

Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, Willett W. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993 Jun;111(6):761-72. 

Dryja TP, McGee TL, Reichel E, Hahn LB, Cowley GS, Yandell DW, Sandberg MA, Berson EL. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature. 1990 Jan 25;343(6256):364-6.

 

 

 

Page updated: April 23, 2014